Status:
COMPLETED
Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization
Lead Sponsor:
Brno University Hospital
Collaborating Sponsors:
Masaryk Memorial Cancer Institute
Masaryk University
Conditions:
Hepatocellular Carcinoma
Hepatocellular Carcinoma by BCLC Stage
Eligibility:
All Genders
18+ years
Brief Summary
The application of transarterial chemoembolisation (TACE) with drug-eluting beads in patients with hepatocellular carcinoma and its response to the treatment will be observed. The registry has the fol...
Detailed Description
The patients with hepatocellular carcinoma in stage suitable for treatment by transarterial chemoembolization (TACE) with drug-eluting beads are included in the study. The investigators assess the res...
Eligibility Criteria
Inclusion
- diagnosis of HCC by a radiologist according to the European Association for the Study of the Liver (EASL) criteria or confirmed histologically
- at least one TACE undergone at the University Hospital Brno
- initial/ closing CT (Brillance 64, Philips, Netherlands; contrast enhancement 125 mL Iomeron 400, Bracco, Germany) or MRI study (Achieva, Philips, Netherlands, SENSE XL Torso coil 16 1.5T; contrast enhancement 15 mL Primovist, Bayer, Germany)
- follow-up on or before December 31, 2019.
Exclusion
- when the inclusion criteria are not met.
Key Trial Info
Start Date :
February 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
61 Patients enrolled
Trial Details
Trial ID
NCT04780789
Start Date
February 1 2015
End Date
December 31 2019
Last Update
March 4 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.